The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: Association with 72-kilodalton metalloproteinase immunostaining

Cancer

Volumn 82, Issue 5, 1998, Pages 886-892

  Garzetti, Gioele G ^a,b   Ciavattini, Andrea ^a   Lucarini, Guendalina ^a   Goteri, Gaia ^a   Menso, Stefano ^a   De Nictolis, Michele ^a   Romanini, Carlo ^a   Biagini, Graziella ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Ospedale Pediatrico G Salesi   (Italy)

Author keywords

Carcinoma; Cervix; Human papillomavirus; Lymph nodes; Lymphatic spread; Polymerase chain reaction; Prognosis

Indexed keywords

COLLAGEN TYPE 4; METALLOPROTEINASE; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

AMINO ACID SEQUENCE; DNA, VIRAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0032030848     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980301)82:5<886::AID-CNCR13>3.0.CO;2-X     Document Type: Article

References (43)

1. Jones WB, Shingleton HM, Russell A, Chmiel JS, Fregmen AM, Clive RE, et al. Patterns of care for invasive cervical cancer. Cancer 1995;76:1936-47.
2. Lin HH, Cheng VF, Chan KW, Chen CK, Huang SC. Risk factor for recurrence in patients with stage Ib, IIa, and IIb cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Obstet Gynecol 1996;88:274-9.
3. Sevin BU, Nadji M, Lampe B, Lu Y, Hilsenbeck S, Koechli OR, et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 1995;76:1978-86.
4. Averette HE, Nguyen HN, Donato D, Penalver MA, Sevin BU Estape R, et al. Radical hysterectomy for early stage cervical cancer: a 25-year prospective experience with the Miami technique. Cancer 1993;71:1422-37.
5. Kamura T, Tsukamoto N, Tsuruchi N, Saito T, Matsuyama T, Akazawa MS. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 1992;69:181-6.
6. Park TW, Fujiwara H, Wright TC. Molecular biology of cervical cancer and its precursors. Cancer 1995;76:1902-13.
7. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
8. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
9. Girardi F, Fuchs P, Haas J. Prognostic importance of human papillomavirus type 16 DNA in cervical cancer. Cancer 1992;69:2502-4.
10. Kenter GG, Cornelisse CJ, Jiwa NM, Aartsen EJ, Hermans J, Mooi W, et al. Human papillomavirus type 16 in tumor tissue of low-stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis. Cancer 1993;71:379-401.
11. Zhang J, Rose BR, Thompson CH, Jarret C, Russel P, Houghton RS. Association between oncogenic human papillomavirus and local invasive patterns in cervical cancer. Gynecol Oncol 1995;57:170-7.
12. Nakagawa S, Yoshikawa H, Onda T, Kawana T, Iwamoto A, Taketani Y. Type of human papillomavirus is related to clinical patterns of cervical carcinoma. Cancer 1996;78:1935-41.
13. Riou G, Le GM, Favre M, Jeannel D, Bourhis J, Orth G. Human papillomavirus-negative status and c-mys gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancers. J Natl Cancer Inst 1992;84:1525-6.
14. Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991;38:910-3.
15. Chen TM, Chen CA, Wu CC, Huang CF, Hsieh CY. The genotypes and prognostic significance of human papillomaviruses in cervical cancer. Int J Cancer 1994;57:181-4.
16. Burger RA, Monk BJ, Kurosaki T, Anton Culver H, Vasilev SA, Berman ML, et al. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996;88:1361-8.
17. Rose BR, Thompson CH, Simpson JM, Jarrett CS, Elliott PM, Tattersall MH, et al. Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: a possible role for type 18. Am J Obstet Gynecol 1995;173:1461-8.
18. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, Romanini C, Biagini G. 72 kDa metalloproteinase immunostaining in cervical carcinoma: relationship with lymph nodal involvement. Gynecol Oncol 1996;60:271-6.
19. Nakajima M, Welch D, Belloni PN, Nicolson GL. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 1987;47:4869-76.
20. Nakajima M, Lotan D, Baig MM, Carralero RM, Wood WR, Hendrix MJC. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res 1989;49:1698-706.
21. Martinez-Hernandez A, Amenta PS. The basement membrane in pathology. Lab Invest 1983;48:656-77.
22. Grigsby PW. Stage Ib1 vs Ib2 carcinoma of the cervix: should the new FIGO staging system define therapy? Gynecol Oncol 1996;62:135-6.
23. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-72.
24. D'Errico A, Biagini G, Garbisa S, Milani M, Rizzoli R, Vasi V, et al. Detection of extracellular matrix antigen (fibronectin, laminin, type IV collagen) in paraffin embedded sections by avidin-biotin-peroxidase complex labeling. Bas Appl Histochem 1986;30:325-32.
25. Daidone MG, Silvestrini R, D'Errico A. Laminin receptors, collagenase IV and prognosis in node negative breast cancer. Int J Cancer 1991;47:529-32.
26. Zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1990;49:4677-81.
27. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer. (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
28. Eluf Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994;69:114-9.
29. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with P53. Science 1990;248:76-9.
30. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-7.
31. Burghardt E, Lahousen M, Stettner H. The significance of pelvic and paraaortic lymphadenectomy in the operative treatment of ovarian cancer. Bailliere's Clin Obstet Gynaecol 1989;3:157-65.
32. Syrjanen K. Immunocompetent cells in uterine cervical lesions of human papillomavirus origin. Gynecol Obstet Invest 1983;16:327-40.
33. Tay SK, Jenkins D, Maddox P, Singer A. Lymphocyte phenotypes in cervical intraepithelial neoplasia and human papillomavirus infection. Br J Obstet Gynaecol 1987;94:16-21.
34. Park JS, Rhyu KS, Kim CJ, Han KT, Ahn HK, Kim SJ, et al. Presence of oncogenic HPV-DNAs in cervical carcinoma tissues and pelvic lymph nodes associating with proliferating cell nuclear antigen expression. Gynecol Oncol 1996;69:418-23.
35. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
36. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Griogioni WG. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 1991;4:239-46.
37. Levy A, Cioce V, Sobel ME, Garbisa S, Griogioni WF, Liotta LA. Increased expression of the 72 KDa type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991; 51:439-44.
38. Monteagudo C, Merino MJ, SanJuan J, Liotta LA, Stetler-Stevenson WG. Immunohistochemical distribution of the type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol 1990;136:585-92.
39. Campo E, Tavassoli FA, Charonis AS, Stetler-Stevenson WG, Liotta LA, Merino MJ. Evaluation of basement membrane components and the 72 KDa type IV collagenase in serous tumors of the ovary. Am J Pathol 1992;6:500-7.
40. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastasis in cell transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52:701-8.
41. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 1992;84:1017-22.
42. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, De Nictolis M, Romanini C, et al. Recurrence patterns in locally advanced cervical carcinoma: role of nodal status and 72 kDa-metalloproteinase index. Gynecol Oncol 1996;61:83-9.
43. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, De Nictolis M, Biagini G. Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining. Gynecol Oncol 1996;61:197-203.